Galectin Therapeutics Executive Chairman James Czirr To Present At Redchip Emerging Growth Showcase
1/23/2014 9:31:57 AM
NORCROSS, Ga., Jan. 23, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (Nasdaq:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that its executive chairman James Czirr will present during the RedChip Emerging Growth Showcase on Thursday, January 23, 2013 at 11:30 a.m. Eastern Standard Time.
Help employers find you! Check out all the jobs and post your resume.
comments powered by